Stomach cancer starts when cells in the stomach lining accumulate enough DNA damage to grow uncontrollably. This doesn’t happen overnight. In most cases, it follows a slow, multi-step process that unfolds over years or even decades, beginning with chronic inflammation that gradually reshapes the stomach’s inner surface. Understanding what drives that process helps explain why some people develop stomach cancer and others don’t.
The Role of H. pylori Infection
The single biggest driver of stomach cancer is a bacterium called Helicobacter pylori. Roughly half the world’s population carries it, though only a small fraction develop cancer. What makes certain strains dangerous is a protein called CagA, which the bacterium injects directly into the cells lining your stomach.
Once inside, CagA hijacks the cell’s normal signaling in several ways. It disrupts the tight junctions that hold stomach lining cells together, causing them to lose their organized structure. Cells that were once neatly arranged start to flatten out, extend finger-like projections, and break down the membranes around them. In lab studies, cells expressing CagA take on characteristics of early cancer cells: they lose their polarity (their sense of “top” and “bottom”), stop adhering to their neighbors, and begin behaving like migrating, invasive cells.
CagA also interferes with your body’s built-in cancer defense. Normally, a protein called p53 acts as a brake, triggering damaged cells to self-destruct before they can become cancerous. CagA blocks this process by binding to a partner protein that suppresses p53’s ability to kill damaged cells, while also speeding up p53’s degradation. The result is that cells with accumulating DNA damage survive when they shouldn’t.
H. pylori is most strongly linked to cancers in the lower and middle portions of the stomach (called non-cardia cancer). Its connection to cancer near the top of the stomach, where it meets the esophagus, is less clear. Studies from Western countries generally find no link between H. pylori and cancer in that upper region, while studies from East Asian countries show a modest association, likely because the anatomy of those cancers differs between populations.
The Slow Path From Inflammation to Cancer
Stomach cancer rarely appears in healthy tissue. It typically follows a well-documented sequence of changes, each one moving the stomach lining a step further from normal. Chronic infection or irritation first causes persistent inflammation of the stomach lining (chronic gastritis). Over time, the stomach’s acid-producing glands begin to thin out and disappear, a condition called atrophy.
Next, the stomach tries to repair itself, but the replacement cells start to resemble cells normally found in the intestine rather than the stomach. This stage, called intestinal metaplasia, is considered a precancerous condition. The annual rate at which intestinal metaplasia progresses to actual cancer is low, generally in the range of 0.5% to 1% per year. That sounds small, but over 10 or 20 years, the cumulative risk becomes significant, which is why doctors sometimes recommend periodic monitoring with endoscopy once this change is detected.
From intestinal metaplasia, cells can develop increasingly abnormal shapes and growth patterns (dysplasia), and eventually cross the line into cancer. The entire sequence, from initial infection to cancer, can span 20 to 30 years. This long timeline is actually an opportunity: catching and treating H. pylori early, or identifying precancerous changes through screening, can interrupt the process before it reaches a dangerous stage.
How Diet Damages Stomach DNA
Certain dietary patterns accelerate the damage that leads to stomach cancer. Processed meats, smoked foods, and pickled vegetables contain compounds called nitrosamines, which are direct-acting carcinogens. When your body metabolizes nitrosamines, they produce reactive molecules that physically attach to your DNA, creating what scientists call “adducts,” essentially molecular scars that distort the genetic code. These adducts, particularly one called O6-alkylguanine, cause errors when cells copy their DNA during division. Over time, enough errors accumulate to disable tumor-suppressing genes or activate cancer-promoting ones.
High salt intake compounds the problem. Salt directly irritates the stomach lining, increases inflammation, and makes the tissue more vulnerable to carcinogens. In populations with very high salt consumption, stomach cancer rates are consistently elevated. Salt also appears to enhance H. pylori’s ability to colonize the stomach and produce its damaging CagA protein, creating a synergy between diet and infection.
Inherited Genetic Risk
A small percentage of stomach cancers are driven primarily by inherited gene mutations rather than environmental factors. The most well-known is a mutation in the CDH1 gene, which provides the blueprint for a protein that helps cells stick together. When CDH1 is defective, stomach lining cells lose their ability to maintain normal tissue architecture, setting the stage for a type called diffuse gastric cancer, where cancer cells spread throughout the stomach wall rather than forming a distinct tumor.
People who carry a CDH1 mutation and have a strong family history of stomach cancer face a lifetime risk generally estimated at 30 to 40 percent, though some studies put the figure as high as 70 percent. Because of this high risk, carriers are often offered preventive removal of the stomach. This hereditary form, known as hereditary diffuse gastric cancer, tends to appear at younger ages than typical stomach cancer and can be difficult to detect with standard endoscopy because it doesn’t always form visible masses.
Why Early Detection Changes Everything
The biology of how stomach cancer starts has a direct implication for survival. When caught while still confined to the stomach wall (localized disease), the five-year survival rate is about 78%. Once it has spread to distant organs, that number drops to roughly 8%. The difference is stark, and it reflects the fact that early-stage stomach cancer is often curable with surgery, while advanced disease is not.
The challenge is that early stomach cancer rarely causes obvious symptoms. The vague discomfort, mild nausea, or loss of appetite it might produce are easy to dismiss as indigestion. In countries like Japan and South Korea, where stomach cancer is common, routine screening with endoscopy catches many cancers early. In the United States and Europe, where the disease is less common, screening is typically reserved for people with known risk factors: a family history of stomach cancer, confirmed H. pylori infection with precancerous changes, or a known CDH1 mutation.
If you have persistent upper abdominal symptoms that don’t respond to standard treatment, a family history of stomach cancer, or you’ve been told you have intestinal metaplasia, those are situations where closer monitoring can catch problems while they’re still highly treatable.